Similar to TIGIT, the expression level of the activating immune checkpoint receptor CD226 was also significantly lower by CD3+ T-, CD4+ T, CD8+ T, and NKT-like cells in women diagnosed with EO preeclampsia compared to the healthy pregnant cohort (Figure 3A). Here, CD226 is linked to preeclampsia.